FDA OKs Danicopan for Extravascular Hemolysis in PNH

A tablet has been approved for a common complication during treatment for a rare blood disorder.

Related Keywords

,Astrazeneca ,Drug Administration ,Risk Evaluation ,Mitigation Strategy ,Patient Safety ,Hemolysis ,Blood ,Blood Transfusion ,Thromboembolism ,Thrombus ,Blood Clot ,Biliary Disease ,Allbladder Disease ,Paroxysmal Nocturnal Hemoglobinuria ,Nh Paroxysmal Nocturnal Hemoglobinuria ,Paroxysmal Nocturnal Haemoglobinuria ,Paroxysmal Nocturnal Hemoglobinuria Pnh ,Covid 19 ,019 Novel Coronavirus ,019 Ncov ,Uhan Coronavirus ,Uman Coronavirus Hku1 ,Uman Coronavirus Oc43 ,